How Stereotaxis Is Making Its Mark in Surgical Robotics: A Journey from Survival to Success episode artwork

EPISODE · Dec 1, 2025 · 30 MIN

How Stereotaxis Is Making Its Mark in Surgical Robotics: A Journey from Survival to Success

from Let’s Talk Medtech

Surgical robotics is changing the landscape in healthcare. Stereotaxis is hoping to carve out its niche in the massive space, which is home to Intuitive Surgical, Johnson & Johnson, and Medtronic.David Fischel, the St. Louis, MO-based company’s chairman and CEO, is featured in this episode of Let’s Talk Medtech to discuss Stereotaxis’ journey from surviving to thriving. The firm recently secured $50 million in funding and has had strong collaborations with NVIDIA.Fischel talks about the company’s game plan and his thoughts on the future of surgical robotics.

Episode metadata supplied by the publisher feed · Published Dec 1, 2025

Embed this episode

Ready to play

How Stereotaxis Is Making Its Mark in Surgical Robotics: A Journey from Survival to Success

0:00 30:31

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Let’s Talk Medtech?

This episode is 30 minutes long.

When was this Let’s Talk Medtech episode published?

This episode was published on December 1, 2025.

Can I download this Let’s Talk Medtech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!